Download PDF
Klin Monbl Augenheilkd 2016; 233(08): 938-944
DOI: 10.1055/s-0042-102060
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Hornhautvernetzung mit Riboflavin und UV-A-Licht bei Keratokonus

Corneal Cross-Linking with Riboflavin and UVA in Keratoconus
F. Raiskup
1   Klinik für Augenheilkunde, Universitätsklinikum C. G. Carus Dresden
,
N. Terai
1   Klinik für Augenheilkunde, Universitätsklinikum C. G. Carus Dresden
,
V. Veliká
2   Klinik für Augenheilkunde, Universitätsklinikum Hradec Králové, Tschechische Republik
,
E. Spörl
1   Klinik für Augenheilkunde, Universitätsklinikum C. G. Carus Dresden
› Author Affiliations
Further Information

Publication History

eingereicht 15 November 2015

akzeptiert 26 January 2016

Publication Date:
07 April 2016 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Beim Keratokonus handelt es sich um eine degenerative ektatische Erkrankung des Auges, bei der die Hornhaut zunehmend ihre Stabilität verliert. Infolgedessen kommt es zu einer Vorwölbung derselben mit zunehmender Stromaausdünnung. Es resultieren ein irregulärer Hornhautastigmatismus sowie eine hohe Myopie, die zu einer progredienten Sehverschlechterung führen. Es sind beide Augen betroffen, allerdings in asymmetrischer Ausprägung. Aufgrund des jungen Alters bei Erstmanifestation übt die Erkrankung einen erheblichen Einfluss auf die weitere Lebensqualität und -planung der Patienten aus. Der Krankheitsverlauf bei dieser primären Hornhautektasie ist sehr variabel und beeinflusst die Entscheidung in Bezug auf die richtige Behandlungsstrategie. Ein international anerkanntes Therapieregime in der Behandlung des progressiv verlaufenden Keratokonus ist die Hornhautkollagenvernetzung, auch „corneal collagen cross-linking“ (CXL) genannt. Dieses Verfahren wird eingesetzt, um ein Fortschreiten dieser Ektasie zu verzögern oder sogar zum Stillstand zu bringen. Die Notwendigkeit einer Hornhautverpflanzung kann damit reduziert werden.

Abstract

Changes in the biomechanical properties of the human cornea play an important role in the pathogenesis of corneal ectatic diseases. Many different pathological conditions in the cornea may reduce its biomechanical resistance. Corneal collagen cross-linking (CXL) has emerged as a promising technique to slow or even to stop the progression of ectasia. In this procedure, riboflavin (vitamin B2) is administered in conjunction with ultraviolet A light (UVA, 365 nm). This interaction causes the formation of reactive oxygen species, leading to additional covalent bonds between collagen molecules, with consequent biomechanical stiffening of the cornea. Although this method is not yet accepted as an evidence-based treatment of corneal ectasia, the results of prospective, randomised studies of CXL used in the treatment of this pathological entity show significant changes in the properties of corneal tissue. This procedure is currently the only aetiopathogenetic treatment of ectatic eyes that can delay or stop the process of cornea destabilisation, reducing the necessity for keratoplasty. Despite promising results, CXL is associated with issues that include long-term safety and duration of the stabilising effect.

Schlüsselwörter

Kornea - Ektasie - Keratokonus - Cross-Linking - Vernetzung

Key words

cornea - ectasia - keratoconus - cross-linking - collagen
 

  • Literatur

  • 1 Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf 2013; 11: 65-74
    CrossrefPubMedGoogle Scholar
  • 2 OʼBrart DP, Patel P, Lascaratos G et al. Corneal cross-linking to halt the progression of keratoconus and corneal ectasia: seven year follow-up. Am J Ophthalmol 2015; 160: 1154-1163
    CrossrefPubMedGoogle Scholar
  • 3 Raiskup F, Theuring A, Pillunat LE et al. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg 2015; 41: 41-46
    PubMedGoogle Scholar
  • 4 Wittig-Silva C, Chan E, Islam FM et al. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results. Ophthalmology 2014; 121: 812-821
    CrossrefPubMedGoogle Scholar
  • 5 Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg 2011; 37: 149-160
    CrossrefPubMedGoogle Scholar
  • 6 Sandvik GF, Thorsrud A, Råen M et al. Does corneal collagen cross-linking reduce the need for keratoplasties in patients with keratoconus?. Cornea 2015; 34: 991-995
    CrossrefPubMedGoogle Scholar
  • 7 Zadnik K, Barr JT, Edrington TB et al. Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci 1998; 39: 2537-2546
    PubMedGoogle Scholar
  • 8 Kymes SM, Walline JJ, Zadnik K et al. Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol 2008; 145: 611-617
    CrossrefPubMedGoogle Scholar
  • 9 Maeno A, Naor J, Lee HM et al. Three decades of corneal transplantation: indications and patient characteristics. Cornea 2000; 19: 7-11
    CrossrefPubMedGoogle Scholar
  • 10 Winkler M, Chai D, Kriling S et al. Nonlinear optical macroscopic assessment of 3-D corneal collagen organization and axial biomechanics. Invest Ophthalmol Vis Sci 2011; 52: 8818-8827
    CrossrefPubMedGoogle Scholar
  • 11 Rehany U, Lahav M, Shoshan S. Collagenolytic activity in keratoconus. Ann Ophthalmol 1982; 14: 751-754
    PubMedGoogle Scholar
  • 12 Wollensak J, Buddecke E. Biochemical studies on human corneal proteoglycans – a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol 1990; 228: 517-523
    CrossrefPubMedGoogle Scholar
  • 13 Sawaguchi S, Yue BY, Chang I et al. Proteoglycan molecules in keratoconus corneas. Invest Ophthalmol Vis Sci 1991; 32: 1846-1853
    PubMedGoogle Scholar
  • 14 Kao WW, Vergnes JP, Ebert J et al. Increased collagenase and gelatinase activities in keratoconus. Biochem Biophys Res Commun 1982; 107: 929-936
    CrossrefPubMedGoogle Scholar
  • 15 Sawaguchi S, Yue BY, Sugar J et al. Lysosomal enzyme abnormalities in keratoconus. Arch Ophthalmol 1989; 107: 1507-1510
    CrossrefPubMedGoogle Scholar
  • 16 Zhou L, Sawaguchi S, Twining SS et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci 1998; 39: 1117-1124
    PubMedGoogle Scholar
  • 17 Daxer A, Fratzl P. Collagen fibril orientation in the human corneal stroma and its implication in keratoconus. Invest Ophthalmol Vis Sci 1997; 38: 121-129
    PubMedGoogle Scholar
  • 18 Radner W, Zehetmayer M, Skorpik C et al. Altered organization of collagen in the apex of keratoconus corneas. Ophthalmic Res 1998; 30: 327-332
    CrossrefPubMedGoogle Scholar
  • 19 Spoerl E, Huhle M, Seiler T. Artificial stiffening of the cornea by induction of intrastromal cross-links. Ophthalmologe 1997; 94: 902-906
    CrossrefPubMedGoogle Scholar
  • 20 Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res 1998; 66: 97-103
    CrossrefPubMedGoogle Scholar
  • 21 Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen cross-linking for the treatment of keratoconus. Am J Ophthalmol 2003; 135: 620-627
    CrossrefPubMedGoogle Scholar
  • 22 Raiskup-Wolf F, Hoyer A, Spoerl E et al. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg 2008; 34: 796-801
    CrossrefPubMedGoogle Scholar
  • 23 Sharma N, Suri K, Sehra SV et al. Collagen cross-linking in keratoconus in Asian eyes: visual, refractive and confocal microscopy outcomes in a prospective randomized controlled trial. Int Ophthalmol 2015; 35: 827-832
    CrossrefPubMedGoogle Scholar
  • 24 Lang SJ, Messmer EM, Geerling G et al. Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus. BMC Ophthalmol 2015; 15: 78
    CrossrefPubMedGoogle Scholar
  • 25 Caporossi A, Mazzotta C, Baiocchi S et al. Age-related long-term functional results after riboflavin UV A corneal cross-linking. J Ophthalmol 2011; 2011: 608041
    PubMedGoogle Scholar
  • 26 Spoerl E, Zubaty V, Terai N et al. Influence of high-dose cortisol on the biomechanics of incubated porcine corneal strips. J Refract Surg 2009; 25: S794-798
    CrossrefPubMedGoogle Scholar
  • 27 Spoerl E, Zubaty V, Raiskup-Wolf F et al. Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol 2007; 91: 1547-1550
    CrossrefPubMedGoogle Scholar
  • 28 Bilgihan K, Hondur A, Sul S et al. Pregnancy-induced progression of keratoconus. Cornea 2011; 30: 991-994
    CrossrefPubMedGoogle Scholar
  • 29 Hafezi F, Iseli HP. Pregnancy-related exacerbation of iatrogenic keratectasia despite corneal collagen crosslinking. J Cataract Refract Surg 2008; 34: 1219-1221
    CrossrefPubMedGoogle Scholar
  • 30 Kappmeyer K, Lanzl IM. Augeninnendruck während und nach dem Spielen von Hoch- und Niedrigwiderstandblasinstrumenten. Ophthalmologe 2010; 107: 41-46
    CrossrefPubMedGoogle Scholar
  • 31 Kuo IC, Broman A, Pirouzmanesh A et al. Is there an association between diabetes and keratoconus?. Ophthalmology 2006; 113: 184-190
    CrossrefPubMedGoogle Scholar
  • 32 Seiler T, Huhle S, Spoerl E et al. Manifest diabetes and keratoconus: a retrospective case-control study. Graefes Arch Clin Exp Ophthalmol 2000; 238: 822-825
    CrossrefPubMedGoogle Scholar
  • 33 Morita A. Tobacco smoke causes premature skin aging. J Dermatol Sci 2007; 48: 169-175
    CrossrefPubMedGoogle Scholar
  • 34 Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003; 41: 183-187
    CrossrefPubMedGoogle Scholar
  • 35 Spoerl E, Raiskup-Wolf F, Kuhlisch E et al. Cigarette smoking is negatively associated with keratoconus. J Refract Surg 2008; 24: S737-740
    PubMedGoogle Scholar
  • 36 Hafezi F, Mrochen M, Iseli HP et al. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg 2009; 35: 621-624
    CrossrefPubMedGoogle Scholar
  • 37 Hafezi F. Limitation of collagen cross-linking with hypoosmolar riboflavin solution: failure in an extremely thin cornea. Cornea 2011; 30: 917-919
    CrossrefPubMedGoogle Scholar
  • 38 Reeves SW, Stinnett S, Adelman RA et al. Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol 2005; 140: 607-611
    PubMedGoogle Scholar
  • 39 Caporossi A, Mazzotta C, Baiocchi S et al. Riboflavin-UVA-induced corneal collagen cross-linking in pediatrics patients. Cornea 2012; 31: 227-231
    CrossrefPubMedGoogle Scholar
  • 40 Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42: 297-319
    CrossrefPubMedGoogle Scholar
  • 41 Ertan A, Muftuoglu O. Keratoconus clinical findings according to different age and gender groups. Cornea 2008; 27: 1109-1113
    CrossrefPubMedGoogle Scholar
  • 42 Cannon DJ, Davison PF. Aging, and crosslinking in mammlian collagen. Exp Aging Res 1977; 3: 87-105
    CrossrefPubMedGoogle Scholar
  • 43 Cannon DJ, Foster CS. Collagen crosslinking in keratoconus. Invest Ophthalmol Vis Sci 1978; 17: 63-65
    PubMedGoogle Scholar
  • 44 Kymionis GD, Portaliou DM, Bouzoukis DI et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 2007; 33: 1982-1984
    CrossrefPubMedGoogle Scholar
  • 45 Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg 2009; 35: 588-589
    CrossrefPubMedGoogle Scholar
  • 46 Rama P, Di Matteo F, Matuska S et al. Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg 2009; 35: 788-791
    CrossrefPubMedGoogle Scholar
  • 47 Zamora KV, Males JJ. Polymicrobial keratitis after a collagen cross-linking procedure with postoperative use of a contact lens: a case report. Cornea 2009; 28: 474-476
    CrossrefPubMedGoogle Scholar
  • 48 Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 2009; 35: 1358-1362
    CrossrefPubMedGoogle Scholar
  • 49 Seiler T, Hafezi F. Corneal cross-linking-induced stromal demarcation line. Cornea 2006; 25: 1057-1059
    CrossrefPubMedGoogle Scholar
  • 50 Herrmann CI, Hammer T, Duncker GI. „Haze“ oder bandförmige Keratopathie nach Crosslinking-Behandlung. Ophthalmologe 2008; 105: 485-487
    CrossrefPubMedGoogle Scholar
  • 51 Mazzotta C, Traversi C, Baiocchi S et al. Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications. Am J Ophthalmol 2008; 146: 527-533
    CrossrefPubMedGoogle Scholar
  • 52 Mazzotta C, Balestrazzi A, Baiocchi S et al. Stromal haze after combined riboflavin-UVA corneal collagen cross-linking in keratoconus: in vivo confocal microscopic evaluation. Clin Experiment Ophthalmol 2007; 35: 580-582
    CrossrefPubMedGoogle Scholar
  • 53 Greenstein SA, Fry KL, Bhatt J et al. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg 2010; 36: 2105-2114
    CrossrefPubMedGoogle Scholar
  • 54 Raiskup F, Hoyer A, Spoerl E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 2009; 25: S824-828
    CrossrefPubMedGoogle Scholar
  • 55 Kymionis GD, Portaliou DM, Diakonis VF et al. Corneal collagen cross-linking with riboflavin and ultraviolet-a irradiation in patients with thin corneas. Am J Ophthalmol 2012; 153: 24-28
    CrossrefPubMedGoogle Scholar
  • 56 Gokhale NS. Corneal endothelial damage after collagen cross-linking treatment. Cornea 2011; 30: 1495-1498
    CrossrefPubMedGoogle Scholar
  • 57 Bagga B, Phuja S, Murthy S. Endothelial failure after collagen cross-linking with riboflavin and UV-A: case report with literature review. Cornea 2012; 31: 1197-1200
    CrossrefPubMedGoogle Scholar
  • 58 Labiris G, Kaloghianni E, Koukoula S et al. Corneal melting after collagen cross-linking for keratoconus: a case report. J Med Case Rep 2011; 5: 152
    CrossrefPubMedGoogle Scholar
  • 59 Gokhale NS, Vemuganti GK. Diclofenac-induced acute corneal melt after collagen crosslinking for keratoconus. Cornea 2010; 29: 117-119
    CrossrefPubMedGoogle Scholar
  • 60 Faschinger C, Kleinert R, Wedrich A. Beidseitiges Einschmelzen der Hornhaut nach beidseitigem simultanen Kollagen-Crosslinking bei Keratokonus und Down-Syndrom. Ophthalmologe 2010; 107: 951-952 954–955
    CrossrefPubMedGoogle Scholar
  • 61 Eberwein P, Auw-Hädrich C, Birnbaum F et al. Hornhauteinschmelzung nach Cross-linking und tiefer lamellärer Keratoplastik („DALK“) bei Keratokonus. Klin Monatsbl Augenheilkd 2008; 225: 96-98
    Article in Thieme ConnectPubMedGoogle Scholar
  • 62 Rebenitsch RL, Kymes SM, Walline JJ et al. The lifetime economic burden of keratoconus: a decision analysis using a Markov model. Am J Ophthalmol 2011; 151: 768-773
    CrossrefPubMedGoogle Scholar
  • 63 Salmon HA, Chalk D, Stein K et al. Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS. Eye (Lond) 2015; 29: 1504-1511
    CrossrefPubMedGoogle Scholar
  • 64 Gomes JAP, Tan D, Rapuano CJ et al. Global Consensus on Keratoconus and Ectatic Diseases. Cornea 2015; 34: 359-369
    CrossrefPubMedGoogle Scholar
  • 65 Craig JA, Mahon J, Yellowlees A et al. Epithelium-off photochemical corneal collagen cross-linkage using riboflavin and ultraviolet a for keratoconus and keratectasia: a systematic review and meta-analysis. Ocul Surf 2014; 12: 202-214
    CrossrefPubMedGoogle Scholar
  • 66 Sykakis E, Karim R, Evans JR et al. Corneal collagen cross-linking for treating keratoconus. Cochrane Database Syst Rev 2015; (3) CD010621
    PubMedGoogle Scholar
  • 67 Meiri Z, Keren S, Rosenblatt A et al. Efficacy of corneal cross-linking for the treatment of keratoconus: a systematic review and meta-analysis. Cornea 2016; 35: 417-428
    CrossrefPubMedGoogle Scholar
  • 68 Vinciguerra P, Albe E, Trazza S et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology 2009; 116: 369-378
    CrossrefPubMedGoogle Scholar